CHEST 2022 Coverage

 

CHEST 2022 Coverage
A

Rituximab in the Treatment of Idiopathic Inflammatory Myopathies With Interstitial Lung Disease: Long Term Follow Up

By CHEST 2022 Coverage FEATURING Anna Khelkovskaya-Sergeeva
By CHEST 2022 Coverage FEATURING Anna Khelkovskaya-Sergeeva
570 views
October 25, 2022
1 Comment
Login to view comments. Click here to Login
ILD
07:21
CHEST 2022 Coverage

Outcomes in Patients With ILD Living in Economically Disadvantaged a…

Feat. H. Kim
53:31
CHEST 2022 Coverage

Approaching Sarcoidosis Therapy From a 21st Century Perspective

Feat. D. Culver
11:22
CHEST 2022 Coverage

Calcium Metabolism and Bones: Sarcoid Hypercalcemia, Kidney Disease …

Feat. P. Sen
21:34
CHEST 2022 Coverage

Management and Treatment Decisions in Progressive Pulmonary Fibrosis

Feat. T. Kulkarni
24:02
CHEST 2022 Coverage

Bronchoscopic Imaging for Interstitial Lung Disease

Feat. G. Zhi Cheng
10:22
CHEST 2022 Coverage

Rituximab in the Treatment of Idiopathic Inflammatory Myopathies Wit…

Feat. A. Khelkovskaya-Sergeeva
19:21
CHEST 2022 Coverage

A Radiologist's Approach to Subsolid Pulmonary Nodules

Feat. A. Guttentag